Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients
1 other identifier
observational
300
0 countries
N/A
Brief Summary
With the extension of the average life expectancy, the incidence of cardiovascular diseases is also rising. Stroke in Taiwan has been the leading cause of morbidity and mortality, but also in countries around the world), stroke and the impact of socio-economic and health spending are large how to reduce the degree of disability after stroke is an important issue in medicine. For a long time, the resident will fill the clinical pathway form before the stroke inpatients were discharged. We also analyzed the data of clinical pathway every three months. According to the current data of stroke clinical pathway included demographic data, length of hospitalization days, complications, functional independent measure, Brunnstrom motor recovery stage, mini-mental state examination, geriatric depression scale, blood pressure data, and post-stroke checklist for a retrospective analysis to provide more complete and more comprehensive information on follow-up care for stroke patients and effective use of medical resources, to improve the quality of future medical care and quality of life for stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 29, 2016
CompletedFirst Posted
Study publicly available on registry
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedJuly 1, 2021
June 1, 2021
5.3 years
November 29, 2016
June 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
functional independent measurement
1 year
post-stroke checklist
1 year
Brunnstrom motor recovery stage
1 year
Eligibility Criteria
stroke inpatient
You may qualify if:
- Ischemic and hemorrhagic stroke patients
- MRI confirmed the diagnosis of stroke
- Within three months of onset of unilateral limb hemiplegia in patients
You may not qualify if:
- Initial tracheostomy impantation and hospital stay is less than 5 days
- Combined with other neurological diseases, such as epilepsy, multiple neuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia or cerebellar atrophy, etc.
- Significant lesions of the lower limb joints, including joint contractures, lower limb fractures, joint replacement or long-term pain in patients with osteoarthritis
- Unstable signs of life (if not through the tilt bed test) or severe cardiopulmonary disease
- Those who can not cooperate with the study or who have not signed the inform consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Physical Medical and Rehabilitation, Principal Investigator,
Study Record Dates
First Submitted
November 29, 2016
First Posted
December 1, 2016
Study Start
November 1, 2016
Primary Completion
February 1, 2022
Study Completion
February 1, 2022
Last Updated
July 1, 2021
Record last verified: 2021-06